Arthur G. Palmer and Oliver Hobert of the Department of Biochemistry & Molecular Biophysics were selected in recognition of their distinguished and continuing achievements in research.
A study co-led by Columbia scientists suggests a nutrient transporter located at the blood-brain barrier could be commandeered to sneak therapeutic drugs into the brain.
Columbia researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
Several faculty members from the VP&S Department of Physiology & Cellular Biophysics gave presentations at the latest in the medical school’s Afternoon of Science series.
A new mouse model may be critical for understanding the most aggressive types of pancreatic cancer and finding ways to prevent its growth and recurrence.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
A newly developed prediction model may be able to calculate the risk of opioid relapse among individuals in the early stages of medication treatment—as early as three weeks into therapy.
As part of a new NIH consortium, scientists will trace how regions targeted by deep brain stimulation connect with the rest of the brain, information that could improve the treatment's efficacy.
With a transformational gift of $6.5 million, the Weinberg Family Cerebral Palsy Center at Columbia University will launch its second decade of excellence in clinical care, research, and education.
Columbia bioengineers are the first to program bacteria that guide immune cells to tumors, which could make more cancers treatable with immunotherapies.
In his new role leading the Chan Zuckerberg Biohub New York, Andrea Califano will bring together scientists from several universities to engineer the immune system to detect and treat disease.
Columbia's Andrea Califano will lead the new Chan Zuckerberg Biohub New York in its mission to harness and engineer immune cells for the early detection and eradication of human disease.